Metacrine logo
Metacrine MTCR

Quarterly report 2022-Q3
added 11-14-2022

report update icon

Metacrine Long Term Debt Current 2011-2026 | MTCR

Annual Long Term Debt Current Metacrine

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
825 K 741 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
825 K 741 K 783 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Veracyte Veracyte
VCYT
4.05 M $ 31.01 -5.46 % $ 2.44 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Vir Biotechnology Vir Biotechnology
VIR
8.8 M $ 8.47 -5.47 % $ 1.17 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Viking Therapeutics Viking Therapeutics
VKTX
137 K $ 32.67 -4.61 % $ 3.68 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
Viridian Therapeutics Viridian Therapeutics
VRDN
753 K $ 27.39 -2.87 % $ 2.79 B usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
VRTX
77.3 M $ 437.99 -3.47 % $ 112 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Verastem Verastem
VSTM
535 K $ 5.01 -5.29 % $ 347 M usaUSA
VistaGen Therapeutics VistaGen Therapeutics
VTGN
561 K $ 0.56 -7.23 % $ 17.3 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
8.92 M $ 12.88 -7.74 % $ 1.95 B usaUSA
vTv Therapeutics vTv Therapeutics
VTVT
154 K $ 38.69 2.35 % $ 152 M usaUSA
Voyager Therapeutics Voyager Therapeutics
VYGR
7.84 M $ 3.97 -4.0 % $ 233 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
45.5 M $ 320.49 -2.34 % $ 42 B usaUSA
Cara Therapeutics Cara Therapeutics
CARA
1.92 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
2.81 M - - $ 3.74 B usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
313 K - - $ 40.5 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Equillium Equillium
EQ
363 K $ 1.93 -6.31 % $ 111 M usaUSA
Amgen Amgen
AMGN
135 M $ 351.01 -0.61 % $ 189 B usaUSA